SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

EU Approves Extended Dosing and Shorter Infusions for Regeneron’s Libtayo

The European Commission approved an alternative Libtayo dosing schedule across all six approved skin, lung and cervical cancer indications. The regimen allows 700 mg every six weeks.

REGN

Related stories